DEA’s Approach To Marijuana Rescheduling Is Creating Deep Uncertainty for Regulators, Patients And Market Operators (Op-Ed)
“Supply chains in many states will not have enough cultivators, manufacturers and dispensaries to support a viable supply chain in either the DEA market or the state-only market.” By Gillian L. Schauer, Cannabis Regulators Association Late last month, the Drug Enforcement Administration (DEA) took three significant actions related to federal medical marijuana rescheduling: issuing guidance […]


